JP2016533332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533332A5 JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nanoparticle
- self
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881848P | 2013-09-24 | 2013-09-24 | |
| US61/881,848 | 2013-09-24 | ||
| PCT/US2014/057240 WO2015048149A1 (en) | 2013-09-24 | 2014-09-24 | Self-assembled nanoparticle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016533332A JP2016533332A (ja) | 2016-10-27 |
| JP2016533332A5 true JP2016533332A5 (enExample) | 2017-11-02 |
Family
ID=51662365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516958A Ceased JP2016533332A (ja) | 2013-09-24 | 2014-09-24 | 自己集合型ナノ粒子ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150110825A1 (enExample) |
| EP (1) | EP3049107A1 (enExample) |
| JP (1) | JP2016533332A (enExample) |
| CA (1) | CA2925201A1 (enExample) |
| WO (1) | WO2015048149A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| EP3250233A4 (en) | 2015-01-29 | 2018-07-25 | Agency for Science, Technology and Research | Nanocapsules carrying chikungunya-associated peptides |
| CA3003886A1 (en) * | 2015-11-06 | 2017-05-11 | University Of South Alabama | Novel platform dna vaccine |
| EP3374504B1 (en) * | 2015-11-09 | 2025-03-19 | CureVac SE | Optimized nucleic acid molecules |
| US10961283B2 (en) | 2016-06-27 | 2021-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類ｂ肝病毒顆粒作為佐劑的疫苗組成物 |
| KR20260047644A (ko) | 2017-03-30 | 2026-04-08 | 더 유니버서티 어브 퀸슬랜드 | 키메라 분자 및 그의 용도 |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| WO2019023811A1 (en) | 2017-08-04 | 2019-02-07 | The Hospital For Sick Children | NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY |
| WO2019135086A1 (en) * | 2018-01-06 | 2019-07-11 | Emergex Vaccines Holding Limited | Mhc class i associated peptides for prevention and treatment of multiple flavi virus |
| WO2019169120A1 (en) | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| JP7412001B2 (ja) * | 2018-06-08 | 2024-01-12 | 株式会社モダリス | 改変されたＣａｓ９タンパク質及びその用途 |
| KR102076917B1 (ko) * | 2018-10-25 | 2020-02-13 | 연세대학교 산학협력단 | 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법 |
| WO2021014385A1 (en) | 2019-07-24 | 2021-01-28 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112439056B (zh) * | 2019-08-28 | 2022-05-31 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用 |
| WO2021245611A1 (en) | 2020-06-05 | 2021-12-09 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN116143949A (zh) * | 2023-02-23 | 2023-05-23 | 中山大学 | 一种水痘-带状疱疹病毒疫苗及其制备方法 |
| CN117567652B (zh) * | 2024-01-19 | 2024-05-14 | 北京安百胜生物科技有限公司 | 一种重组呼吸道合胞病毒颗粒抗原 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200613552A (en) * | 2004-08-11 | 2006-05-01 | Hoffmann La Roche | Mutant interleukin-15 polypeptides |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| JP5711972B2 (ja) * | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| CA2835644C (en) * | 2011-05-13 | 2021-06-15 | Novartis Ag | Pre-fusion rsv f antigens |
| US20130049342A1 (en) * | 2011-08-25 | 2013-02-28 | James Michael Cottrell | Trailer chassis hold down system |
| EP2758038B1 (en) * | 2011-09-23 | 2018-05-30 | The United States of America, as represented by The Secretary, Department of Health & Human Services | Novel influenza hemagglutinin protein-based vaccines |
| RU2014117068A (ru) * | 2011-09-30 | 2015-11-10 | Новавакс, Инк. | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса |
| EP2970398B1 (en) * | 2013-03-13 | 2024-05-08 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
-
2014
- 2014-09-24 JP JP2016516958A patent/JP2016533332A/ja not_active Ceased
- 2014-09-24 US US14/495,640 patent/US20150110825A1/en not_active Abandoned
- 2014-09-24 WO PCT/US2014/057240 patent/WO2015048149A1/en not_active Ceased
- 2014-09-24 EP EP14781401.6A patent/EP3049107A1/en not_active Withdrawn
- 2014-09-24 CA CA2925201A patent/CA2925201A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016533332A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| Patterson et al. | Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza | |
| JP2015501840A5 (enExample) | ||
| US20130236491A1 (en) | Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes | |
| JP2015508284A5 (enExample) | ||
| JP2013517773A5 (enExample) | ||
| JP2014500724A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| Mao et al. | Surface display on lactic acid bacteria without genetic modification: strategies and applications | |
| JP2016501829A5 (enExample) | ||
| JP2012509071A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| CN117534735A (zh) | 腺病毒外壳蛋白衍生递送载体 | |
| JP2012515557A5 (enExample) | ||
| JP2018524019A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| WO2022043449A1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| Lee et al. | Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery | |
| JP2016520534A5 (enExample) | ||
| JP6964518B2 (ja) | ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化 | |
| JP2010538619A5 (enExample) | ||
| JP2019502404A5 (enExample) |